FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

16255011000001107: Accuretic 12.5mg/10mg tablets (Mawdsley-Brooks & Company Ltd) 30 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 04-Jan 2010. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
57335601000001119 Accuretic 12.5mg/10mg tablets (Mawdsley-Brooks & Company Ltd) 30 tablet (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
110938101000001116 Accuretic 10mg/12.5mg tablets (Mawdsley-Brooks & Company Ltd) 30 tablet en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Accuretic 12.5mg/10mg tablets (Mawdsley-Brooks & Company Ltd) 30 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Accuretic 12.5mg/10mg tablets (Mawdsley-Brooks & Company Ltd) 30 tablet Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Accuretic 12.5mg/10mg tablets (Mawdsley-Brooks & Company Ltd) 30 tablet Has NHS dm+d (dictionary of medicines and devices) parallel import indicator Parallel import true Inferred relationship Existential restriction modifier
Accuretic 12.5mg/10mg tablets (Mawdsley-Brooks & Company Ltd) 30 tablet Discontinued indicator Discontinued AMPP(qualifier value) true Inferred relationship Existential restriction modifier
Accuretic 12.5mg/10mg tablets (Mawdsley-Brooks & Company Ltd) 30 tablet Is a Hydrochlorothiazide 12.5mg / Quinapril 10mg tablets 30 tablet true Inferred relationship Existential restriction modifier
Accuretic 12.5mg/10mg tablets (Mawdsley-Brooks & Company Ltd) 30 tablet Has AMP Accuretic 12.5mg/10mg tablets (Mawdsley-Brooks & Company Ltd) true Inferred relationship Existential restriction modifier
Accuretic 12.5mg/10mg tablets (Mawdsley-Brooks & Company Ltd) 30 tablet Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Accuretic 12.5mg/10mg tablets (Mawdsley-Brooks & Company Ltd) 30 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Accuretic 12.5mg/10mg tablets (Mawdsley-Brooks & Company Ltd) 30 tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Accuretic 12.5mg/10mg tablets (Mawdsley-Brooks & Company Ltd) 30 tablet Has specific active ingredient Quinapril hydrochloride true Inferred relationship Existential restriction modifier
Accuretic 12.5mg/10mg tablets (Mawdsley-Brooks & Company Ltd) 30 tablet Has specific active ingredient Hydrochlorothiazide true Inferred relationship Existential restriction modifier
Accuretic 12.5mg/10mg tablets (Mawdsley-Brooks & Company Ltd) 30 tablet Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Accuretic 12.5mg/10mg tablets (Mawdsley-Brooks & Company Ltd) 30 tablet Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Quinapril true Inferred relationship Existential restriction modifier
Accuretic 12.5mg/10mg tablets (Mawdsley-Brooks & Company Ltd) 30 tablet Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Accuretic 12.5mg/10mg tablets (Mawdsley-Brooks & Company Ltd) 30 tablet Discontinued indicator Never discontinued false Inferred relationship Existential restriction modifier
Accuretic 12.5mg/10mg tablets (Mawdsley-Brooks & Company Ltd) 30 tablet Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Accuretic 12.5mg/10mg tablets (Mawdsley-Brooks & Company Ltd) 30 tablet Has basis of strength substance Quinapril true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start